发明名称 |
INTRANASAL FORMULATIONS OF INTERFERON BETA FREE OF STABILIZERS THAT ARE PROTEINS OR POLYPEPTIDES. |
摘要 |
<p>Compositions and methods are provided for intranasal delivery of interferon-ß yielding improved pharmacokinetic and pharmacodynamic results wherein the composition is free of a stabilizer that is a protein or a polypeptide. In certain aspects of the invention, the interferon-ß is delivered to the intranasal mucosa along with one or more intranasal delivery-enhancing agent(s) to yield substantially increased absorption and/or bioavailability of the interferon-ß and/or a substantially decreased time to maximal concentration of interferon-ß in a tissue of a subject as compared to controls where the interferon-ß is administered to the same intranasal site alone or formulated according to previously disclosed reports. The enhancement of intranasal delivery of interferon-ß according to the methods and compositions of the present invention allows for the effective pharmaceutical use of these agents to treat a variety of diseases and conditions in mammalian subjects.</p> |
申请公布号 |
MXPA06014215(A) |
申请公布日期 |
2007.05.04 |
申请号 |
MX2006PA14215 |
申请日期 |
2005.06.07 |
申请人 |
NASTECH PHARMACEUTICAL COMPANY INC. |
发明人 |
STEVEN C. QUAY;HENRY R. COSTANTINO |
分类号 |
A61K9/00;A61K38/21;A61K47/00;A61P31/12 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|